G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 12.94 CNY -6.71% Market Closed
Market Cap: 5.3B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one GemPharmatech Co Ltd stock under the Base Case scenario is 20.3 CNY. Compared to the current market price of 12.94 CNY, GemPharmatech Co Ltd is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
20.3 CNY
Undervaluation 36%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation Backtest
GemPharmatech Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GemPharmatech Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GemPharmatech Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about GemPharmatech Co Ltd

Provide an overview of the primary business activities
of GemPharmatech Co Ltd.

What unique competitive advantages
does GemPharmatech Co Ltd hold over its rivals?

What risks and challenges
does GemPharmatech Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for GemPharmatech Co Ltd.

Provide P/S
for GemPharmatech Co Ltd.

Provide P/E
for GemPharmatech Co Ltd.

Provide P/OCF
for GemPharmatech Co Ltd.

Provide P/FCFE
for GemPharmatech Co Ltd.

Provide P/B
for GemPharmatech Co Ltd.

Provide EV/S
for GemPharmatech Co Ltd.

Provide EV/GP
for GemPharmatech Co Ltd.

Provide EV/EBITDA
for GemPharmatech Co Ltd.

Provide EV/EBIT
for GemPharmatech Co Ltd.

Provide EV/OCF
for GemPharmatech Co Ltd.

Provide EV/FCFF
for GemPharmatech Co Ltd.

Provide EV/IC
for GemPharmatech Co Ltd.

Show me price targets
for GemPharmatech Co Ltd made by professional analysts.

What are the Revenue projections
for GemPharmatech Co Ltd?

How accurate were the past Revenue estimates
for GemPharmatech Co Ltd?

What are the Net Income projections
for GemPharmatech Co Ltd?

How accurate were the past Net Income estimates
for GemPharmatech Co Ltd?

What are the EPS projections
for GemPharmatech Co Ltd?

How accurate were the past EPS estimates
for GemPharmatech Co Ltd?

What are the EBIT projections
for GemPharmatech Co Ltd?

How accurate were the past EBIT estimates
for GemPharmatech Co Ltd?

Compare the revenue forecasts
for GemPharmatech Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of GemPharmatech Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of GemPharmatech Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of GemPharmatech Co Ltd compared to its peers.

Compare the P/E ratios
of GemPharmatech Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing GemPharmatech Co Ltd with its peers.

Analyze the financial leverage
of GemPharmatech Co Ltd compared to its main competitors.

Show all profitability ratios
for GemPharmatech Co Ltd.

Provide ROE
for GemPharmatech Co Ltd.

Provide ROA
for GemPharmatech Co Ltd.

Provide ROIC
for GemPharmatech Co Ltd.

Provide ROCE
for GemPharmatech Co Ltd.

Provide Gross Margin
for GemPharmatech Co Ltd.

Provide Operating Margin
for GemPharmatech Co Ltd.

Provide Net Margin
for GemPharmatech Co Ltd.

Provide FCF Margin
for GemPharmatech Co Ltd.

Show all solvency ratios
for GemPharmatech Co Ltd.

Provide D/E Ratio
for GemPharmatech Co Ltd.

Provide D/A Ratio
for GemPharmatech Co Ltd.

Provide Interest Coverage Ratio
for GemPharmatech Co Ltd.

Provide Altman Z-Score Ratio
for GemPharmatech Co Ltd.

Provide Quick Ratio
for GemPharmatech Co Ltd.

Provide Current Ratio
for GemPharmatech Co Ltd.

Provide Cash Ratio
for GemPharmatech Co Ltd.

What is the historical Revenue growth
over the last 5 years for GemPharmatech Co Ltd?

What is the historical Net Income growth
over the last 5 years for GemPharmatech Co Ltd?

What is the current Free Cash Flow
of GemPharmatech Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for GemPharmatech Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
GemPharmatech Co Ltd

Current Assets 1.7B
Cash & Short-Term Investments 1.3B
Receivables 380.8m
Other Current Assets 61m
Non-Current Assets 870.1m
Long-Term Investments 99m
PP&E 638.1m
Intangibles 54.6m
Other Non-Current Assets 78.5m
Current Liabilities 426.6m
Accounts Payable 94.6m
Accrued Liabilities 33.5m
Short-Term Debt 108.1m
Other Current Liabilities 190.5m
Non-Current Liabilities 74.3m
Long-Term Debt 37.4m
Other Non-Current Liabilities 37m
Efficiency

Earnings Waterfall
GemPharmatech Co Ltd

Revenue
666.7m CNY
Cost of Revenue
-232.2m CNY
Gross Profit
434.5m CNY
Operating Expenses
-302.1m CNY
Operating Income
132.4m CNY
Other Expenses
25.3m CNY
Net Income
157.7m CNY

Free Cash Flow Analysis
GemPharmatech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

GemPharmatech Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Net Income
Positive Operating Income
Positive 3-Year Average ROIC
56/100
Profitability
Score

GemPharmatech Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

GemPharmatech Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

GemPharmatech Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
GemPharmatech Co Ltd

Wall Street analysts forecast GemPharmatech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GemPharmatech Co Ltd is 18.43 CNY with a low forecast of 16.8 CNY and a high forecast of 20.48 CNY.

Lowest
Price Target
16.8 CNY
30% Upside
Average
Price Target
18.43 CNY
42% Upside
Highest
Price Target
20.48 CNY
58% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GemPharmatech Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GemPharmatech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

GemPharmatech Co Ltd

Country

China

Industry

Life Sciences Tools & Services

Market Cap

5.3B CNY

Dividend Yield

1.47%

Description

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Contact

JIANGSU
Nanjing
No. 12 Xuefu Road, Jiangbei New Area
+862558265927
www.gempharmatech.com

IPO

2022-04-25

Employees

1 342

Officers

CEO, GM, Secretary & Director
Dr. Jing Zhao Ph.D.
Chief Technology Officer
Dr. Hong-Yu Wang Ph.D.
Chief Data Officer
Dr. Tremain Ju Ph.D.
Deputy Director of Functional Pharmacodynamics Center
Hongyan Sun
General Manager of American Medicine
Mr. Mark W. Moore

See Also

Discover More
What is the Intrinsic Value of one GemPharmatech Co Ltd stock?

The intrinsic value of one GemPharmatech Co Ltd stock under the Base Case scenario is 20.3 CNY.

Is GemPharmatech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 12.94 CNY, GemPharmatech Co Ltd is Undervalued by 36%.

Back to Top